Research Article
BibTex RIS Cite

Synthesis and structure-activity relationship study: Anticancer chalcones derived from 4′-morpholinoacetophenone

Year 2017, Volume: 21 Issue: 4, 949 - 960, 01.12.2017

Abstract

The aim of this research was to synthesize chalcone
derivatives containing morpholine ring and to investigate
their antiproliferative activity. The 3-aryl-1-[4-(morpholin-
4-yl)phenyl]prop-2-en-1-one derivatives were synthesized
and evaluated for their in vitro antiproliferative activities
on C6 cells (Rat glioma cell line) and HeLa cells (Human
cervix adenocarcinoma), using the BrdU ELISA assay. The
calculation of ADME properties of new chalcone derivatives
was used by topological polar surface area (TPSA), absorption
(ABS%) and Lipinski’s rules. Most of the compounds exhibited
significantly antiproliferative activity on two cell lines. Among
the screened compounds, compound 7, 10, 11 and 12 revealed
higher antiproliferative activity than cisplatin which was used
as reference drug. Compound 11 on HeLa cell and compound
10 on C6 cell line are the most effective compared with
cisplatin.

References

  • 1. Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 2005; 13: 5043-54. 2. Sashidhara KV, Kumar A, Kumar M, Sarkar J, Sinha S. Synthesis and in vitro evaluation of novel coumarin -chalcone hybrids as potential Anticancer agents. Bioorg Med Chem 2010; 24: 7205-11. 3. Hatzade K, Taile V, Gaidhane P, Ingle V. Synthesis, structural determination, and biological activity of new 7-hydroxy-3- pyrazolyl-4H-chromen- 4-ones and their o-b-D-glucosides. Turk J Chem 2010; 34: 241-54. 4. Campos-Buzzi F, Padaratz P, Meira AV, Corrêa R, Nunes RJ, Cechinel-Filho V. 4’-Acetamidochalcone derivatives as potential antinociceptive agents. Molecules 2007; 12: 896-906. 5. Modzelewska A, Pettit C, Achanta G, Davidson NE, Huang P, Khan SR. Anticancer activities of novel chalcone and bischalcone derivatives. Bioorg Med Chem 2006; 14: 3491-5. 6. Zhang L, Wang X, Wang J, Grinberg N, Krishnamurthy DK, Senanayake CH. An improved method of amide synthesis using acyl chlorides. Tetrahedron Lett 2009; 50: 2964-6. 7. Bandgar BP, Gawande SS, Bodade RG, Gawande NM, Khobragade CN. Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents. Bioorg Med Chem 2009;17: 8168-73. 8. Tiwari V, Ali P, Meshram J. Microwave assisted synthesis of 3-(2-chloroguiolin-3-yl)-1-substituted phenyl prop-2-en-1- ones using K2CO3 as a mild, cheap and ınexpensive catalyst. Int J Chem Tech Res 2010; 2: 1031-5. 9. Boeck P, Falcao CAB, Leal PC, Yunes RA, Filho VC, Torres- Santos EC, Rossi-Bergmann B. Synthesis of chalcone analogues with increased antileishmanial activity. Bioorg Med Chem 2006; 14: 1538-45. 10. Ceylan M, Gurdere MB, Karaman I, Gezegen H. Synthesis and screening antimicrobial activities of novel 1,3-diaryl-3- (phenylthio)propan-1-one derivatives. Med Chem Res 2011; 20: 109-15. 11. Mishra N, Arora P, Kumar B, Mishra LC, Bhattacharya A, Awasthi SK, Bhasin VK. Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in vitro. Eur J Med Chem 2008; 43: 1530-5. 12. Wheeler OH, Gore PH, Santiago M, Baez R. Ultraviolet Absorption of Substituted Phenyl and Polycyclic aryl Chalcones. Canadian J Chem 1964; 42: 2580-3. 13. Rizvi SUF, Siddiqui HL, Johns M, Detorio M, Schinazi RF. Anti-HIV-1 and cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives. Med Chem Res 2012; 21: 3741-9. 14. a) Kursun BS, Oruç-Emre EE, Karaküçük-İyidoğan A, Şahin A, Tekin Ş, Demirtaş İ. Antiproliferative activity of the substituted morpholine derivatives chalcone. Turkish Patent Institute, TPE 2011/05601, 2011. b) Kursun BS, Oruç-Emre EE, Karaküçük-İyidoğan A, Şahin A, Tekin Ş, Demirtaş İ. Antiproliferative activity of the substituted morpholine derivatives chalcone. Turkish Patent Institute, TPE 2013/04957, 2013. 15. Demirtas I, Sahin A. Bioactive volatile content of the stem and root of Centaurea carduiformis DC. subsp. carduiformis var. carduiformis. E-J Chem 2012; 2013. 16. Demirtas I, Sahin A, Ayhan B, Tekin S, Telci I. antiproliferative effects of the methanolic extracts of Sideritis libanotica Labill. subsp. linearis. Rec Nat Prod 2009; 3: 104-9. 17. Gopalakrishnan M, Thanusu J, Kanagarajan V, Govindaraju R. Synthesis, antibacterial, and antifungal activities of biolabile (E)-1-(4-morpholinophenyl)-3-aryl-prop-2-en-1- ones. Med Chem Res 2009; 18: 341-50. 18. Silverstein RM, Bassler GC, Merrill TC. Spectrometric Identification of Organic Compounds. John Wiley & Sons,Inc, Singapore. 1991. 19. Palibroda N. Electron ionisation mass spectra of some substituted chalcones. Studia Universitatis Babes-Bolyai, Physica, L 2005; 4b: 34-38. 20. Okwu DE, Ukanwa N. Isolation and characterization of flavonoids chalcones and anthocynidines from bridelia ferruginea benth. Der Chemica Sinica 2010; 1: 21-8. 21. Azev YA, Dülcks T, Gabel D. Cyanuric and thiocyanuric esters as carriers of boron-containing fragments and their fragmentation in mass spectrometry. Tetrahedron Lett 2003; 344: 8689-91. 22. Sato T, Ashizawa N, Iwanaga T, Nakamura H, Matsumoto K, Inoue T, Nagata O. Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl- 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors. Bioorg Med Chem Lett 2009; 19:184-7. 23. Luzina EL, Popov AV. Synthesis and anticancer activity of N-bis(trifluoromethyl)alkyl-N’-thiazolyl and N-bis(trifluoromethyl)alkyl-N’-benzothiazolyl ureas. Eur J Med Chem 2009; 44: 4944-53. 24. Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I. Rate-limited steps of human oral absorption and QSAR studies. Pharm Res 2012;19: 1446-57.
Year 2017, Volume: 21 Issue: 4, 949 - 960, 01.12.2017

Abstract

References

  • 1. Jaracz S, Chen J, Kuznetsova LV, Ojima I. Recent advances in tumor-targeting anticancer drug conjugates. Bioorg Med Chem 2005; 13: 5043-54. 2. Sashidhara KV, Kumar A, Kumar M, Sarkar J, Sinha S. Synthesis and in vitro evaluation of novel coumarin -chalcone hybrids as potential Anticancer agents. Bioorg Med Chem 2010; 24: 7205-11. 3. Hatzade K, Taile V, Gaidhane P, Ingle V. Synthesis, structural determination, and biological activity of new 7-hydroxy-3- pyrazolyl-4H-chromen- 4-ones and their o-b-D-glucosides. Turk J Chem 2010; 34: 241-54. 4. Campos-Buzzi F, Padaratz P, Meira AV, Corrêa R, Nunes RJ, Cechinel-Filho V. 4’-Acetamidochalcone derivatives as potential antinociceptive agents. Molecules 2007; 12: 896-906. 5. Modzelewska A, Pettit C, Achanta G, Davidson NE, Huang P, Khan SR. Anticancer activities of novel chalcone and bischalcone derivatives. Bioorg Med Chem 2006; 14: 3491-5. 6. Zhang L, Wang X, Wang J, Grinberg N, Krishnamurthy DK, Senanayake CH. An improved method of amide synthesis using acyl chlorides. Tetrahedron Lett 2009; 50: 2964-6. 7. Bandgar BP, Gawande SS, Bodade RG, Gawande NM, Khobragade CN. Synthesis and biological evaluation of a novel series of pyrazole chalcones as anti-inflammatory, antioxidant and antimicrobial agents. Bioorg Med Chem 2009;17: 8168-73. 8. Tiwari V, Ali P, Meshram J. Microwave assisted synthesis of 3-(2-chloroguiolin-3-yl)-1-substituted phenyl prop-2-en-1- ones using K2CO3 as a mild, cheap and ınexpensive catalyst. Int J Chem Tech Res 2010; 2: 1031-5. 9. Boeck P, Falcao CAB, Leal PC, Yunes RA, Filho VC, Torres- Santos EC, Rossi-Bergmann B. Synthesis of chalcone analogues with increased antileishmanial activity. Bioorg Med Chem 2006; 14: 1538-45. 10. Ceylan M, Gurdere MB, Karaman I, Gezegen H. Synthesis and screening antimicrobial activities of novel 1,3-diaryl-3- (phenylthio)propan-1-one derivatives. Med Chem Res 2011; 20: 109-15. 11. Mishra N, Arora P, Kumar B, Mishra LC, Bhattacharya A, Awasthi SK, Bhasin VK. Synthesis of novel substituted 1,3-diaryl propenone derivatives and their antimalarial activity in vitro. Eur J Med Chem 2008; 43: 1530-5. 12. Wheeler OH, Gore PH, Santiago M, Baez R. Ultraviolet Absorption of Substituted Phenyl and Polycyclic aryl Chalcones. Canadian J Chem 1964; 42: 2580-3. 13. Rizvi SUF, Siddiqui HL, Johns M, Detorio M, Schinazi RF. Anti-HIV-1 and cytotoxicity studies of piperidyl-thienyl chalcones and their 2-pyrazoline derivatives. Med Chem Res 2012; 21: 3741-9. 14. a) Kursun BS, Oruç-Emre EE, Karaküçük-İyidoğan A, Şahin A, Tekin Ş, Demirtaş İ. Antiproliferative activity of the substituted morpholine derivatives chalcone. Turkish Patent Institute, TPE 2011/05601, 2011. b) Kursun BS, Oruç-Emre EE, Karaküçük-İyidoğan A, Şahin A, Tekin Ş, Demirtaş İ. Antiproliferative activity of the substituted morpholine derivatives chalcone. Turkish Patent Institute, TPE 2013/04957, 2013. 15. Demirtas I, Sahin A. Bioactive volatile content of the stem and root of Centaurea carduiformis DC. subsp. carduiformis var. carduiformis. E-J Chem 2012; 2013. 16. Demirtas I, Sahin A, Ayhan B, Tekin S, Telci I. antiproliferative effects of the methanolic extracts of Sideritis libanotica Labill. subsp. linearis. Rec Nat Prod 2009; 3: 104-9. 17. Gopalakrishnan M, Thanusu J, Kanagarajan V, Govindaraju R. Synthesis, antibacterial, and antifungal activities of biolabile (E)-1-(4-morpholinophenyl)-3-aryl-prop-2-en-1- ones. Med Chem Res 2009; 18: 341-50. 18. Silverstein RM, Bassler GC, Merrill TC. Spectrometric Identification of Organic Compounds. John Wiley & Sons,Inc, Singapore. 1991. 19. Palibroda N. Electron ionisation mass spectra of some substituted chalcones. Studia Universitatis Babes-Bolyai, Physica, L 2005; 4b: 34-38. 20. Okwu DE, Ukanwa N. Isolation and characterization of flavonoids chalcones and anthocynidines from bridelia ferruginea benth. Der Chemica Sinica 2010; 1: 21-8. 21. Azev YA, Dülcks T, Gabel D. Cyanuric and thiocyanuric esters as carriers of boron-containing fragments and their fragmentation in mass spectrometry. Tetrahedron Lett 2003; 344: 8689-91. 22. Sato T, Ashizawa N, Iwanaga T, Nakamura H, Matsumoto K, Inoue T, Nagata O. Design, synthesis, and pharmacological and pharmacokinetic evaluation of 3-phenyl-5-pyridyl- 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors. Bioorg Med Chem Lett 2009; 19:184-7. 23. Luzina EL, Popov AV. Synthesis and anticancer activity of N-bis(trifluoromethyl)alkyl-N’-thiazolyl and N-bis(trifluoromethyl)alkyl-N’-benzothiazolyl ureas. Eur J Med Chem 2009; 44: 4944-53. 24. Zhao YH, Abraham MH, Le J, Hersey A, Luscombe CN, Beck G, Sherborne B, Cooper I. Rate-limited steps of human oral absorption and QSAR studies. Pharm Res 2012;19: 1446-57.
There are 1 citations in total.

Details

Subjects Health Care Administration
Journal Section Articles
Authors

Bedriye Seda Kurşun-aktar

Emine Elçin Oruç-emre

Ayşegül Karaküçük-iyidoğan This is me

Ayse Şahin Yağlıoğlu This is me

İbrahim Demirtaş This is me

Şaban Tekin This is me

Publication Date December 1, 2017
Published in Issue Year 2017 Volume: 21 Issue: 4

Cite

APA Kurşun-aktar, B. S., Oruç-emre, E. E., Karaküçük-iyidoğan, A., Şahin Yağlıoğlu, A., et al. (2017). Synthesis and structure-activity relationship study: Anticancer chalcones derived from 4′-morpholinoacetophenone. Marmara Pharmaceutical Journal, 21(4), 949-960.
AMA Kurşun-aktar BS, Oruç-emre EE, Karaküçük-iyidoğan A, Şahin Yağlıoğlu A, Demirtaş İ, Tekin Ş. Synthesis and structure-activity relationship study: Anticancer chalcones derived from 4′-morpholinoacetophenone. J Res Pharm. December 2017;21(4):949-960.
Chicago Kurşun-aktar, Bedriye Seda, Emine Elçin Oruç-emre, Ayşegül Karaküçük-iyidoğan, Ayse Şahin Yağlıoğlu, İbrahim Demirtaş, and Şaban Tekin. “Synthesis and Structure-Activity Relationship Study: Anticancer Chalcones Derived from 4′-Morpholinoacetophenone”. Marmara Pharmaceutical Journal 21, no. 4 (December 2017): 949-60.
EndNote Kurşun-aktar BS, Oruç-emre EE, Karaküçük-iyidoğan A, Şahin Yağlıoğlu A, Demirtaş İ, Tekin Ş (December 1, 2017) Synthesis and structure-activity relationship study: Anticancer chalcones derived from 4′-morpholinoacetophenone. Marmara Pharmaceutical Journal 21 4 949–960.
IEEE B. S. Kurşun-aktar, E. E. Oruç-emre, A. Karaküçük-iyidoğan, A. Şahin Yağlıoğlu, İ. Demirtaş, and Ş. Tekin, “Synthesis and structure-activity relationship study: Anticancer chalcones derived from 4′-morpholinoacetophenone”, J Res Pharm, vol. 21, no. 4, pp. 949–960, 2017.
ISNAD Kurşun-aktar, Bedriye Seda et al. “Synthesis and Structure-Activity Relationship Study: Anticancer Chalcones Derived from 4′-Morpholinoacetophenone”. Marmara Pharmaceutical Journal 21/4 (December 2017), 949-960.
JAMA Kurşun-aktar BS, Oruç-emre EE, Karaküçük-iyidoğan A, Şahin Yağlıoğlu A, Demirtaş İ, Tekin Ş. Synthesis and structure-activity relationship study: Anticancer chalcones derived from 4′-morpholinoacetophenone. J Res Pharm. 2017;21:949–960.
MLA Kurşun-aktar, Bedriye Seda et al. “Synthesis and Structure-Activity Relationship Study: Anticancer Chalcones Derived from 4′-Morpholinoacetophenone”. Marmara Pharmaceutical Journal, vol. 21, no. 4, 2017, pp. 949-60.
Vancouver Kurşun-aktar BS, Oruç-emre EE, Karaküçük-iyidoğan A, Şahin Yağlıoğlu A, Demirtaş İ, Tekin Ş. Synthesis and structure-activity relationship study: Anticancer chalcones derived from 4′-morpholinoacetophenone. J Res Pharm. 2017;21(4):949-60.

.